India Pencillins Profile
Key Indicators
- Authorised Capital ₹ 9.30 M
- Paid Up Capital ₹ 9.28 M
- Company Age 32 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 1.25 Cr
- Revenue Growth -14.80%
- Profit Growth 46.86%
- Ebitda 14.29%
- Net Worth -25.56%
- Total Assets -8.46%
About India Pencillins
India Pencillins Limited (IPL) is a Public Limited Indian Non-Government Company incorporated in India on 21 September 1992 and has a history of 32 years and four months. Its registered office is in Andhra Pradesh, Telangana.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 9.30 M and a paid-up capital of Rs 9.28 M.
The company has closed loans amounting to ₹1.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sri Perambudur, Venkateshwar Oddiraju, and Murali Pullagummi serve as directors at the Company.
Company Details
-
LocationAndhra Pradesh, Telangana
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230TG1992PLC014774
-
Company No.
014774
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
21 Sep 1992
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at India Pencillins?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sri Perambudur
|
Director | 30-May-2019 | Current |
|
Venkateshwar Oddiraju
|
Director | 26-Jul-2019 | Current |
|
Murali Pullagummi
|
Director | 26-Jul-2019 | Current |
Financial Performance of India Pencillins.
India Pencillins Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 14.8% decrease. The company also saw a substantial improvement in profitability, with a 46.86% increase in profit. The company's net worth observed a substantial decline by a decrease of 25.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of India Pencillins?
In 2019, India Pencillins had a promoter holding of 50.43% and a public holding of 49.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹12.52 M
Charges Breakdown by Lending Institutions
- A.P.S.F.C. : 1.16 Cr
- State Bank Of India : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2002 | A.P.S.F.C. | ₹1.16 Cr | Satisfied |
| 27 May 1999 | State Bank Of India | ₹0.90 M | Satisfied |
How Many Employees Work at India Pencillins?
Unlock and access historical data on people associated with India Pencillins, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of India Pencillins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped India Pencillins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
